Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence

Laura Buggio, Elena Roncella, Roncella E, Edgardo Somigliana, Paolo Vercellini
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2015 · vol. 32(4) , pp. 259–263 · doi:10.3109/09513590.2015.1111329 · PMID:26490176 · W2173863779
Review OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This review critically analyzes current evidence suggesting a link between vitamin D metabolism and the development of gynecological diseases like endometriosis, uterine fibroids, and polycystic ovary syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Vitamin D is a fat-soluble pro-hormone that plays an important role in bone homeostasis; beside this principal function, vitamin D promotes modulation of cell growth, neuromuscular and immune function, and reduction of inflammation. In addition, several in vitro and in vivo studies have demonstrated that vitamin D deficiency could increase the risk of cancer, autoimmune and cardiovascular diseases. Moreover, vitamin D plays also an important role in female reproduction, because vitamin D receptors are expressed in ovarian tissue, endometrium, fallopian epithelial cells as well as in decidua and placenta. We aimed to review the most updated evidence, which suggests a link between vitamin D metabolism and the development of some gynaecological diseases, such as endometriosis, uterine fibroids and polycystic ovary syndrome.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Genital Diseases, Female Vitamin D Female Female Genital Diseases, Female Genital Diseases, Female Genital Diseases, Female Humans Humans Vitamin D Vitamin D

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (51)

Cited by (6)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:16:42.682428+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK